NIH to host a summit on SARS-CoV-2 antiviral therapeutics development
The National Institutes of Health (NIH) plans to host the Virtual SARS-CoV-2 Antiviral Therapeutics Summit on November 6, 2020, to discuss progress and remaining challenges in developing antiviral treatments for COVID-19, according to a press release.
Experts from academia, industry, NIH and other parts of the federal government will discuss such topics as SARS-CoV-2 targets for drug development and tools to test promising antiviral drug candidates. They also will identify unmet research needs, share lessons learned from other infectious diseases, and explore opportunities for public-private partnerships.
The meeting is sponsored by NIH's National Center for Advancing Translational Sciences and National Institute of Allergy and Infectious Diseases. The meeting is virtual and can be viewed live or archived on NIH's videocast website. Registration is not required.
